Additionally diabetes technologies such as continuous subcutaneous insulin infusions(CSII,insulin pumps) were mostly concentrated in minority of clinics, meaning that young adults from outside these clinics’ catchment areas had fewer opportunities to obtain these devices. This evidence concerns the gene INS and diabetes mellitus.